Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias.

Journal of cardiovascular electrophysiology - 1 Jun 2000

Napolitano C, Schwartz P J, Brown A M, Ronchetti E, Bianchi L, Pinnavaia A, Acquaro G, Priori S G

Abstract excerpt

The aim of this study was to test the hypothesis that some cases of drug-induced arrhythmias depend on genetic predisposition. Excessive prolongation of the QT interval and life-threatening arrhythmias (torsades de pointes or ventricular fibrillation) may occur in response to a variety of cardiac...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arrhythmias, Cardiac
Share to Critical Illness
Share to Gastrointestinal Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to KCNQ Potassium Channels

Share to KCNQ1 Potassium Channel

Share to Long QT Syndrome

Share to Potassium Channels

Share to Potassium Channels, Voltage-Gated

Source

Identifiers

PMID: 10868744
DOI: 10.1111/j.1540-8167.2000.tb00033.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-10868744-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias.PMID 10868744Read ↗

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.Semantic proximity Read ↗

Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes.Semantic proximity Read ↗

Pharmacogenomics and Acquired Long QT SyndromeSemantic proximity Read ↗

Genetic basis of drug-induced arrhythmias.Semantic proximity Read ↗

Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.Semantic proximity Read ↗

Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.Semantic proximity Read ↗

Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.Semantic proximity Read ↗

QT interval prolongation and cardiac risk assessment for novel drugs.Semantic proximity Read ↗

Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationSemantic proximity Read ↗

Pharmacogenetic considerations in diseases of cardiac ion channels.Semantic proximity Read ↗

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.Semantic proximity Read ↗

Molecular predictors of drug-induced prolongation of the QT interval.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.